Cardiovascular effects of ATG and OKT3 in renal allograft recipients

Transplant Proc. 1992 Dec;24(6):2594-5.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antilymphocyte Serum / administration & dosage
  • Antilymphocyte Serum / adverse effects*
  • Blood Pressure / drug effects*
  • Cadaver
  • Female
  • Graft Rejection / immunology
  • Graft Rejection / therapy*
  • Graft Survival / drug effects*
  • Graft Survival / immunology
  • Heart Rate / drug effects*
  • Humans
  • Kidney Transplantation / immunology*
  • Male
  • Middle Aged
  • Muromonab-CD3 / administration & dosage
  • Muromonab-CD3 / adverse effects*
  • Postoperative Complications / immunology
  • Postoperative Complications / therapy*

Substances

  • Antilymphocyte Serum
  • Muromonab-CD3